LAUSR

The dynamic topological states of chromosomal DNA regulate many cellular fundamental processes universally in all three domains of life, that is, bacteria, archaea, and eukaryotes. DNA‐binding proteins maintain the regional and global supercoiling of the chromosome and thereby regulate the chromatin architecture that ultimately influences the gene expression network and other DNA‐centric molecular events in various microenvironments and growth phases. DNA‐binding small molecules are pivotal weapons for treating a wide range of cancers. Recent advances in single‐molecule biophysical tools have uncovered the fact that many DNA‐binding ligands not only alter the regional DNA supercoiling but also modulate the overall morphology of DNA. Here we provide insight into recent advances in atomic force microscopy (AFM) acquired DNA structural change induced by therapeutically important mono‐ and bis‐intercalating anticancer agents as well as DNA‐adduct‐forming anticancer drugs. We also emphasize the growing evidence of the mechanistic relevance of changes in DNA topology in the anticancer cellular responses of DNA‐targeting chemotherapeutic agents.